Overall IRON gets a fundamental rating of 2 out of 10. We evaluated IRON against 525 industry peers in the Biotechnology industry. While IRON seems to be doing ok healthwise, there are quite some concerns on its profitability. IRON has a expensive valuation and it also scores bad on growth.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -28.73% | ||
| ROE | -31.59% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 30.12 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 23.45 | ||
| Quick Ratio | 23.45 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 2 / 10 to IRON.
ChartMill assigns a valuation rating of 0 / 10 to DISC MEDICINE INC (IRON). This can be considered as Overvalued.
DISC MEDICINE INC (IRON) has a profitability rating of 1 / 10.